Shilpa Medicare Commissions Advanced ADC Manufacturing Facility

🧬 $SHILPAMED announced that its subsidiary Shilpa Biologicals Private Limited has commissioned a state-of-the-art Antibody-Drug Conjugate (ADC) GMP Manufacturing Facility. The facility is now fully operational, with GMP qualification protocols currently underway, strengthening the group's capabilities in high-value biologics and oncology-focused therapeutics.